{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-22-003069","form_type":"8-K","ticker":"PHIO","cik":"0001533040","company_name":"Phio Pharmaceuticals Corp.","filed_at":"2022-05-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.100479+00:00","generated_at":"2026-06-26T02:02:31.920190+00:00","sec_items":["5.02","5.03","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Phio appoints Patricia A. Bradford to board; amends bylaws on director count","bullets":["Board size increased to eight; Patricia A. Bradford appointed effective April 27, 2022.","Bradford is former SVP Global HR at Unisys; not assigned to any board committee initially.","Bylaws amended to let board fix director number by resolution; previously capped at seven.","Bradford will receive standard non-employee director compensation and indemnification.","No material transactions or arrangements with Bradford or family per Item 404(a)."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-22-003069","json":"https://secwatch.observer/filing/0001683168-22-003069.json","markdown":"https://secwatch.observer/filing/0001683168-22-003069.md","text":"https://secwatch.observer/filing/0001683168-22-003069.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533040/000168316822003069/0001683168-22-003069-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533040/000168316822003069/phio_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T02:02:31.920190+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a080ba9622","claim":"Patricia A. Bradford was appointed as Director at Phio Pharmaceuticals Corp..","evidence_excerpt":"Effective as of April 27, 2022, the Board of Directors (the “Board”) of Phio Pharmaceuticals Corp. (the “Company”) increased the size of the Board to eight members and appointed Patricia A. Bradford, former Senior Vice President Global Human Resources, Unisys Corporation, to serve on the Board until the 2022 annual meeting of stockholders.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1533040/000168316822003069/0001683168-22-003069-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}